SCHEMBL21313868

SCHEMBL21313868

O=C(c1ccc2[nH]nnc2c1)N1C=C2CN(C(=O)/C=C/c3ccccc3)C[C@@H]2C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ GPR183 P32249 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ENPP2 Q13822 1/20 0.34
▸ ATXN2 Q99700 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963404 1.00 RAB9A (0.43) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL21313918 0.89 GPR183 (0.43) GPR183CYP1A2
SCHEMBL16963563 0.89 GPR183 (0.43) GPR183CYP1A2
SCHEMBL16961653 0.89 GPR183 (0.35) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL21314079 0.89 GPR183 (0.35) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL21313929 0.89 GHSR (0.35) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL16963192 0.89 GHSR (0.35) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL16961534 0.89 HTR2B (0.38) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL21313985 0.89 HTR2B (0.38) RAB9AMAPTHPGDNPC1SMN1; SMN2
SCHEMBL21313927 0.87 HTR2B (0.36) RAB9AMAPTHPGDNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback